Home Drug Injury Rezulin Liver Damage Settlement

Rezulin Liver Damage Settlement

Rezulin (troglitazone) was a “new” type of antidiabetic medication introduced in 1997 to treat Type 2 diabetes. Originally rejected due to concerns about liver damage, the drug was approved for the market in March 1997, only to be withdrawn in March 2000 due to at least 430 cases of liver failure being reported in patients. Seeger Weiss was a court-appointed member of the Plaintiffs’ Executive Committee, and the firm played a pivotal role in securing an estimated $750 million on behalf of patients who were harmed after taking Rezulin.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Jul 28, 2025
Rezulin Liver Damage Lawsuit Settlement

What’s on this page:

Firm News

April 1, 2026
Seeger Weiss Welcomes Former Assistant U.S. Attorney Michael Castiglione as Firm Continues to Build Deep Bench of Talented Attorneys

Seeger Weiss is proud to announce that Michael Castiglione has joined the firm as Counsel, bringing nearly two decades of experience in in high-stakes litigation, government investigations, and complex civil matters. Castiglione comes to Seeger Weiss following more than a decade as an Assistant United States Attorney (AUSA) in the Eastern District of New York, […]

Read More
March 30, 2026
Ten Seeger Weiss Attorneys Named To The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide

Seeger Weiss is proud to announce that ten Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, and Caleb Seeley on this well-deserved recognition. […]

Read More
March 26, 2026
Jury Finds Meta and YouTube Liable in Landmark California Social Media Addiction Trial

A California jury has found Meta and YouTube negligent in designing platforms that harmed a young user, ordering Meta to pay $4.2 million and YouTube to pay $1.8 million in combined compensatory and punitive damages, in what is being called a landmark verdict in social media addiction litigation. Seeger Weiss Founding Partner Christopher Seeger serves […]

Read More
March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More